Skip to main content
Journal ArticleOPEN ACCESS

Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first-line treatment of advanced non-small cell lung cancer: A generic protocol

Cochrane Database of Systematic Reviews (2018) 2018(4)
DOI: 10.1002/14651858.CD013009
7Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the effectiveness and toxicity of immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy alone as first-line treatment of advanced non-small cell lung cancer (NSCLC).

Cite

CITATION STYLE

APA

Syn, N. L. X., Roudi, R., Wang, L. Z., Wang, L., Loh, M., Huang, Y., … Wee, I. (2018). Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first-line treatment of advanced non-small cell lung cancer: A generic protocol. Cochrane Database of Systematic Reviews, 2018(4). https://doi.org/10.1002/14651858.CD013009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free